Skip to contentClarengateINTELLIGENCE
Companies/NI668614

Reprogo Limited

Research and experimental development on biotechnology · Belfast

ActiveUnited KingdomIncorporated 2020Private Limited Company
Register Ask analyst

Financial position

Accounts to 2026-03-31 · GBP · Company accounts

Net assets
£39,746
Cash
—
Turnover
—
Profit / loss
—
Current assets
£43,887
Creditors < 1 year
£4,181
Equity
£39,746
Average employees
1

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

6 periods
Reported figures2026-03-3112 months · Company2025-03-3112 months · Company2024-03-31Company2023-03-3112 months2022-03-3112 months2021-03-3113 months
Balance sheet
Net assets£39,746£40,216£26,946£72,594£138,662£0
Equity£39,746£40,216£26,946£72,594£138,662£0
Assets
Fixed assets£40£40£40£40£40£0
Current assets£43,887£62,005£31,590£75,726£139,622£0
Liabilities
Creditors within one year£4,181£21,229£3,924£3,172£1,000£0
Net current assets£39,706£40,776£27,666£72,554£138,622£0
Assets less current liabilities£39,746£40,816£27,706£72,594£138,662£0
People & pay
Average employees11—320
Source evidenceView filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.